GGrantIndex
← Leaderboards

Min Liu

University Of Cincinnati

$6,642,557
Attributed
$11,551,007
Total exposure
6
Grants
4
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.5M · FY200522
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22

Funding mix

By agency

NIH$11,995,551 · 7

By mechanism

R01$11,551,007 · 6
U2C$444,544 · 1

Top collaborators

Most similar at University Of Cincinnati

Same institution · by research overlap

Others in their field

Top investigators on “Mediating

Research focus

MediatingSignal TransductionRattusPhysiologicalInnovationPreventResponseBaseAreaObesityBrainEatingProteinsHomeostasisPeripheralSatiationReportingUnited StatesBody WeightChronicEpidemicPathway InteractionsLipidsDose

Grant awards (31)

Role of the GI lymphatic system in hormonal signaling and nutrient metabolism$593,944
R01 · FY2022 · DK · contact PI
Role of the GI lymphatic system in hormonal signaling and nutrient metabolism$593,943
R01 · FY2021 · DK · contact PI
Smarter exosomes derived from engineered MSCs promote neo-vascularization$505,044
R01 · FY2021 · HL
Cincinnati Mouse Metabolic Phenotyping Center$444,544
U2C · FY2021 · DK · contact PI
Role of the GI lymphatic system in hormonal signaling and nutrient metabolism$593,943
R01 · FY2020 · DK
Smarter exosomes derived from engineered MSCs promote neo-vascularization$505,044
R01 · FY2020 · HL
The therapeutic potential of smarter exosomes derived from engineered MSCs on Alzheimer's disease$401,250
R01 · FY2020 · HL
Role of the GI lymphatic system in hormonal signaling and nutrient metabolism$593,943
R01 · FY2019 · DK
Smarter exosomes derived from engineered MSCs promote neo-vascularization$504,388
R01 · FY2019 · HL
Role of the GI lymphatic system in hormonal signaling and nutrient metabolism$616,764
R01 · FY2018 · DK
Smarter exosomes derived from engineered MSCs promote neo-vascularization$502,815
R01 · FY2018 · HL
Ginsenocide Rb1: A Novel Anti-Obesity and Anti-Hyperglycemic Compound$329,700
R01 · FY2016 · DK
Brain apoA-IV Mediates Estrogenic Reduction of Dietary Obesity in Female Rats$347,755
R01 · FY2015 · DK · contact PI
Ginsenocide Rb1: A Novel Anti-Obesity and Anti-Hyperglycemic Compound$329,700
R01 · FY2015 · DK
Brain apoA-IV Mediates Estrogenic Reduction of Dietary Obesity in Female Rats$347,755
R01 · FY2014 · DK · contact PI
Ginsenocide Rb1: A Novel Anti-Obesity and Anti-Hyperglycemic Compound$329,700
R01 · FY2014 · DK
Brain apoA-IV Mediates Estrogenic Reduction of Dietary Obesity in Female Rats$335,584
R01 · FY2013 · DK · contact PI
Ginsenocide Rb1: A Novel Anti-Obesity and Anti-Hyperglycemic Compound$318,161
R01 · FY2013 · DK
Brain apoA-IV Mediates Estrogenic Reduction of Dietary Obesity in Female Rats$347,755
R01 · FY2012 · DK · contact PI
Ginsenocide Rb1: A novel Anti-Obesity and Anti-Hyperglycemic Compound$329,700
R01 · FY2012 · DK
Brain apoA-IV mediates estrogenic reduction of dietary obesity in female rats$392,500
R01 · FY2011 · DK · contact PI
Regulation of Food Intake and Body Weight by Brain Apo E$276,451
R01 · FY2011 · DK · contact PI
Regulation of Food Intake and Body Weight by Brain Apo E$279,243
R01 · FY2010 · DK · contact PI
Regulation of Food Intake and Body Weight by Brain Apo E$282,064
R01 · FY2009 · DK · contact PI
Regulation of Food Intake and Body Weight by Brain Apo E$282,064
R01 · FY2008 · DK · contact PI
Regulation of Food Intake and Body Weight by Brain Apo E$287,820
R01 · FY2007 · DK · contact PI
Brain Apolipoprotein AIV, Food Intake and Obesity$241,061
R01 · FY2007 · DK · contact PI
Brain Apolipoprotein AIV, Food Intake and Obesity$248,260
R01 · FY2006 · DK · contact PI
Brain Apolipoprotein AIV, Food Intake and Obesity$254,234
R01 · FY2005 · DK
Brain Apolipoprotein AIV, Food Intake and Obesity$254,234
R01 · FY2004 · DK
Brain Apolipoprotein AIV, Food Intake and Obesity$326,188
R01 · FY2003 · DK